Compounds and compositions as TRK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8637516
APP PUB NO 20120065184A1
SERIAL NO

13227957

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS INC DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION10675 JOHN JAY HOPKINS DRIVE SAN DIEGO CA 92121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Albaugh, Pamela A Redlands, US 18 504
Chopiuk, Gregory Vancouver, CA 2 72
Fan, Yi Poway, US 137 991
Flatt, Brenton T Poway, US 22 479
Loren, Jon San Diego, US 22 379
Molteni, Valentina San Diego, US 56 467
Smith, Jeffrey M San Diego, US 41 1181

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 28, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00